[pending] RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)
Pending LLM rewrite. Source: FDA_DRUG D-0533-2025.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
The recalled product
- Product
- RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)
- Brand
- RIZATRIPTAN BENZOATE
- Manufacturer
- Ascend Laboratories, LLC
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot 23142117
- 23142119
- 23142122
- Exp Date: May 2026
- Lot 24142625
- Exp Date: Jun. 2027
UPCs (1)
- 0367877261300
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · RIZATRIPTAN BENZOATE
- HighFDA Recalls Rizatriptan Benzoate Tablets for Manufacturing Impurity
FDA (Drugs) · 2024-06-12
- HighPrescription migraine drug recalled for manufacturing impurity above FDA limit
FDA (Drugs) · 2024-06-12
- HighRizatriptan Benzoate Tablets Recalled for Excessive N-Nitroso Impurity
FDA (Drugs) · 2024-06-12
- HighPrescription Rizatriptan Benzoate Tablets Recalled for Chemical Impurity
FDA (Drugs) · 2024-06-12
- ModerateRizatriptan Benzoate Tablets Recalled for Out-of-Specification Impurities
FDA (Drugs) · 2021-11-03
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22